Back to Authors

Lew, Mark

A5008303763 | I1174212

Mayo Clinic

University of Southern California

Citations 4

ANCHOR-CD ( A bobotulinumtoxinA N eurotoxin: C linical and H ealth Economics O utcomes

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p07.191

A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease

JAMA Neurology | March 25, 2014 | Volume: 71 | Issue: 5 | Pages: 543

10.1001/jamaneurol.2014.131 | PMID 24664227

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia

Neurology | May 13, 2012 | Volume: 53 | Issue: 7 | Pages: 1431-1431

10.1212/wnl.53.7.1431 | PMID 10534247

Activity enhances dopaminergic long-duration response in Parkinson disease

Neurology | March 30, 2012 | Volume: 78 | Issue: 15 | Pages: 1146-1149

10.1212/wnl.0b013e31824f8056 | PMID 22459675